ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 164 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,876,000 | -27.4% | 168,915 | -26.8% | 1.49% | -27.5% |
| Q3 2016 | $16,361,000 | -1.0% | 230,628 | -31.7% | 2.06% | -12.3% |
| Q2 2016 | $16,521,000 | -13.3% | 337,788 | +12.2% | 2.34% | -6.8% |
| Q1 2016 | $19,062,000 | -17.7% | 301,091 | +45.8% | 2.52% | -7.6% |
| Q4 2015 | $23,172,000 | +16.3% | 206,559 | -0.2% | 2.72% | +17.9% |
| Q3 2015 | $19,925,000 | -25.0% | 206,880 | -20.3% | 2.31% | -14.4% |
| Q2 2015 | $26,584,000 | – | 259,633 | – | 2.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |